PLUR
Pluri, Inc.
NASDAQ · Healthcare · Biotechnology · IL
$1.08
+0.00%Margins
Gross margin
44.6%
EBITDA margin
-2362.6%
EBIT margin
-2455.9%
Net margin
-2406.0%
FCF margin
-1990.3%
106.1%
Return on equity
-98.3%
Return on assets
-210.1%
Return on invested capital
0.04x
Asset turnover
-$19.6M
Cash from operations
$0.63
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026